132 related articles for article (PubMed ID: 9059292)
21. Mammographic screening after the age of 65 years: evidence for a reduction in breast cancer mortality.
Van Dijck JA; Verbeek AL; Beex LV; Hendriks JH; Holland R; Mravunac M; Straatman H; Werre JM
Int J Cancer; 1996 Jun; 66(6):727-31. PubMed ID: 8647640
[TBL] [Abstract][Full Text] [Related]
22. The association between the pre-diagnosis mammography screening interval and advanced breast cancer.
Goel A; Littenberg B; Burack RC
Breast Cancer Res Treat; 2007 May; 102(3):339-45. PubMed ID: 16927175
[TBL] [Abstract][Full Text] [Related]
23. MR Imaging as an Additional Screening Modality for the Detection of Breast Cancer in Women Aged 50-75 Years with Extremely Dense Breasts: The DENSE Trial Study Design.
Emaus MJ; Bakker MF; Peeters PH; Loo CE; Mann RM; de Jong MD; Bisschops RH; Veltman J; Duvivier KM; Lobbes MB; Pijnappel RM; Karssemeijer N; de Koning HJ; van den Bosch MA; Monninkhof EM; Mali WP; Veldhuis WB; van Gils CH
Radiology; 2015 Nov; 277(2):527-37. PubMed ID: 26110667
[TBL] [Abstract][Full Text] [Related]
24. Cost-effectiveness of digital mammography screening before the age of 50 in The Netherlands.
Sankatsing VD; Heijnsdijk EA; van Luijt PA; van Ravesteyn NT; Fracheboud J; de Koning HJ
Int J Cancer; 2015 Oct; 137(8):1990-9. PubMed ID: 25895135
[TBL] [Abstract][Full Text] [Related]
25. Second round cancers: how many were visible on the first round of the UK National Breast Screening Programme, three years earlier?
Daly CA; Apthorp L; Field S
Clin Radiol; 1998 Jan; 53(1):25-8. PubMed ID: 9464431
[TBL] [Abstract][Full Text] [Related]
26. The comparative value of mammographic screening for women 40-49 years old versus women 50-64 years old.
Curpen BN; Sickles EA; Sollitto RA; Ominsky SH; Galvin HB; Frankel SD
AJR Am J Roentgenol; 1995 May; 164(5):1099-103. PubMed ID: 7717212
[TBL] [Abstract][Full Text] [Related]
27. Age-specific effectiveness of the Nijmegen population-based breast cancer-screening program: assessment of early indicators of screening effectiveness.
Peer PG; Holland R; Hendriks JH; Mravunac M; Verbeek AL
J Natl Cancer Inst; 1994 Mar; 86(6):436-41. PubMed ID: 8120918
[TBL] [Abstract][Full Text] [Related]
28. Screening interval breast cancers: mammographic features and prognosis factors.
Burrell HC; Sibbering DM; Wilson AR; Pinder SE; Evans AJ; Yeoman LJ; Elston CW; Ellis IO; Blamey RW; Robertson JF
Radiology; 1996 Jun; 199(3):811-7. PubMed ID: 8638010
[TBL] [Abstract][Full Text] [Related]
29. Minority report - false negative breast assessment in women recalled for suspicious screening mammography: imaging and pathological features, and associated delay in diagnosis.
Ciatto S; Houssami N; Ambrogetti D; Bonardi R; Collini G; Del Turco MR
Breast Cancer Res Treat; 2007 Sep; 105(1):37-43. PubMed ID: 17115112
[TBL] [Abstract][Full Text] [Related]
30. A blind review and an informed review of interval breast cancer cases in the Limburg screening programme, the Netherlands.
de Rijke JM; Schouten LJ; Schreutelkamp JL; Jochem I; Verbeek AL
J Med Screen; 2000; 7(1):19-23. PubMed ID: 10807142
[TBL] [Abstract][Full Text] [Related]
31. [Results of the first round of mammographic screening at local health unit No. 43, Leno, Lombardy (Brescia)].
Cirelli L; Donato F; Carafa M; Spiazzi R
Radiol Med; 1989 Apr; 77(4):382-5. PubMed ID: 2727340
[TBL] [Abstract][Full Text] [Related]
32. Positive predictive value of screening mammography by age and family history of breast cancer.
Kerlikowske K; Grady D; Barclay J; Sickles EA; Eaton A; Ernster V
JAMA; 1993 Nov; 270(20):2444-50. PubMed ID: 8230621
[TBL] [Abstract][Full Text] [Related]
33. Interval cancers in the Dutch breast cancer screening programme.
Fracheboud J; de Koning HJ; Beemsterboer PM; Boer R; Verbeek AL; Hendriks JH; van Ineveld BM; Broeders MJ; de Bruyn AE; van der Maas PJ
Br J Cancer; 1999 Nov; 81(5):912-7. PubMed ID: 10555768
[TBL] [Abstract][Full Text] [Related]
34. Mammography screening in the Netherlands: delay in the diagnosis of breast cancer after breast cancer screening.
Duijm LE; Groenewoud JH; Jansen FH; Fracheboud J; van Beek M; de Koning HJ
Br J Cancer; 2004 Nov; 91(10):1795-9. PubMed ID: 15505630
[TBL] [Abstract][Full Text] [Related]
35. Survival in interval breast cancer in the DOM screening programme.
Brekelmans CT; Peeters PH; Deurenberg JJ; Collette HJ
Eur J Cancer; 1995 Oct; 31A(11):1830-5. PubMed ID: 8541108
[TBL] [Abstract][Full Text] [Related]
36. Mammography in symptomatic and asymptomatic patients.
Stomper PC; Gelman RS
Hematol Oncol Clin North Am; 1989 Dec; 3(4):611-40. PubMed ID: 2691492
[TBL] [Abstract][Full Text] [Related]
37. Axillary node dissection in patients with breast cancer diagnosed through the Ontario Breast Screening Program: a need for minimally invasive techniques.
Singhal H; O'Malley FP; Tweedie E; Stitt L; Tonkin KS
Can J Surg; 1997 Oct; 40(5):377-82. PubMed ID: 9336528
[TBL] [Abstract][Full Text] [Related]
38. The significance of spontaneous resolution of breast calcification.
Seymour HR; Cooke J; Given-Wilson RM
Br J Radiol; 1999 Jan; 72(853):3-8. PubMed ID: 10341682
[TBL] [Abstract][Full Text] [Related]
39. Bilateral breast cancer: early detection with mammography.
Roubidoux MA; Helvie MA; Lai NE; Paramagul C
Radiology; 1995 Aug; 196(2):427-31. PubMed ID: 7617856
[TBL] [Abstract][Full Text] [Related]
40. Risk factors for breast cancer in women undergoing mammography.
Reuter KL; Baker SP; Krolikowski FJ
AJR Am J Roentgenol; 1992 Feb; 158(2):273-8. PubMed ID: 1729780
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
